TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 2 | 1 | -17 | -5 | -14 | -5 |
| P | %wins | 100 | 67 | 67 | 0 | 50 | 50 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/2/20 14:22 | 11/19/19 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Henderson John T | CA | D | P | 51 | 8.57 | 0 | 6 | 999% | 6 | D | ||||||||||||||||
11/7/19 13:05 | 11/7/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson John T | UT | D | P | 164 | 23.46 | 0 | 7 | 12 | 66 | M | |||||||||||||||
2/23/17 11:20 | 2/22/17 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson John T | UT | D | P.m | 112 | 18.66 | 33 | 6 | 16 | 43 | D | -46 | -46 | -11 | 12 | 8 | 17 | 18 | 9 | 1 | 3 | 2 | ||||
5/14/09 11:07 | 5/13/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson John T | UT | D | P | 10 | 32.73 | 33 | 0 | 8 | 4 | I | 74 | 57 | -9 | -25 | -28 | -15 | -14 | 6 | 0 | 3 | 17 | -10 | -19 | -36 | |
5/11/04 17:48 | 5/11/04 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson John T | UT | D | P | 34 | 17.03 | 16 | 2 | New | 2 | D | -23 | 21 | 33 | -4 | 5 | 0 | -9 | -9 | 3 | -1 | -15 | -23 | 9 | 8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |